Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community
MRSA - Methicillin Resistant Staphylococcus Aureus Infection
About this trial
This is an interventional prevention trial for MRSA - Methicillin Resistant Staphylococcus Aureus Infection focused on measuring MRSA; household; infection; colonization
Eligibility Criteria
Inclusion Criteria:
- All members of a household in which the index case is treated for a skin or soft tissue infection due to MRSA. All household members must agree to participate in order for the household to be enrolled
Exclusion Criteria:
- Prior MRSA within past 6 months in the index case; age less than 6 months.
Sites / Locations
- Hershey Medical Center
- Children's Hospital of Philadelphia
- Hospital of the University of Pennsylvania
- Penn Presbyterian Medical Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
Unsupervised Decolonization
Supervised Decolonization
No Intervention
Households undergo decolonization for MRSA. The intervention includes applying Mupirocin ointment twice daily for the first 7 days of study enrollment as well as using Hibliclens body wash twice total (on day 1 and day 7 of study enrollment) according to the instructions provided.
Households undergo decolonization for MRSA. The intervention includes applying Mupirocin ointment twice daily for the first 7 days of study enrollment as well as using Hibliclens body wash twice total (on day 1 and day 7 of study enrollment) according to the instructions provided. Study staff is in contact with household members during this intervention to ensure compliance.
Households do not undergo active MRSA decolonization protocol